Perelman School of Medicine

New data from an Internet-based study show that patients with head and neck cancers (HNC) may be at risk for significant late effects after their treatment, but they're unlikely to discuss these and other survivorship care issues with their doctors.

Katie Delach ・May 31, 2012

Individual use of prescription opioids has increased four-fold since the mid-1990s, in part due to increased awareness of pain control for chronic conditions such as low back pain and fibromyalgia and a Joint Commission mandate that hospitals assess patients' pain as a "vital sign" along with their blood pressure and temperature.

Holly Auer ・May 30, 2012

The Perelman School of Medicine at the University of Pennsylvania, in collaboration with the University of Pennsylvania School of Nursing and School of Dental Medicine, has been designated a national Center of Excellence in Pain Educa

Jessica Mikulski ・May 30, 2012

Among patients with malignant pleural mesothelioma, treatment with lung-sparing surgery in combination with photodynamic therapy (PDT) yielded unusually long survival rates, with median survival rates up to two or more years longer than is reported with traditional treatments, according to new research from the Perelman School of Medicine at the Univ

Jessica Mikulski ・May 29, 2012

A new study published by researchers at the Perelman School of Medicine at the University of Pennsylvania, the Broad Institute, and Massachusetts General Hospital, challenges the conventional concept that raising a person's HDL levels (good cholesterol) will always help lower their risk of a heart attack.

Jessica Mikulski ・May 17, 2012

PHILADELPHIA — Targeted drug delivery is one of the more enticing applications of nanotechnology; by designing pharmaceuticals on an atomic scale, engineers hope to get them attacking diseases with newfound precision and efficiency.

Evan Lerner ・May 17, 2012

A team from the Perelman School of Medicine and the Abramson Family Cancer Research Institute at the University of Pennsylvania found that the FDA-approved drug daclizumab improved the survival of breast cancer patients taking a cancer vaccine by 30 percent, compared to those patients not taking

Karen Kreeger ・May 16, 2012

Black cardiac arrest victims who are stricken outside hospitals are less likely to receive bystander CPR and defibrillation on the scene than white patients, according to research that will be presented by a research team from the Perelman School of Medicine at the University of Pennsylvania today at the annual meeting of

Holly Auer ・May 14, 2012

Perelman School of Medicine at the University of Pennsylvania researchers have discovered a mechanism involving the neurotransmitter dopamine that switches fruit fly behavior from being active during the day (diurnal) to nocturnal.

Karen Kreeger ・May 14, 2012

A new electronic medical record tool that tallies patients' previous radiation exposure from CT scans helps reduce potentially unnecessary use of the tests among emergency room patients with abdominal pain, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania that will be presented to

Holly Auer ・May 14, 2012